Nadia Kazemipour

Nadia Kazemipour

Auto-generated profile, based on publicly available information

Nadia Kazemipour

Department of Microbiology, Kerman Branch, Islamic Azad University, Kerman, Iran

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Microbial Pathogenesis
Verified
Journal Article
Closed access
ABArezoo Bassagh
Arezoo Bassagh
AJAbdollah Jafarzadeh
Abdollah Jafarzadeh
NKNadia Kazemipour
Nadia Kazemipour
MNMaryam Nemati
Maryam Nemati
NANajmeh Aminizadeh
Najmeh Aminizadeh
EMEhsan Mirkamandar
Ehsan Mirkamandar

1 September 2019 in Iranian Journal of Medical Microbiology
Verified
Journal Article
Open access
PDF file
MRMaryam Rezaei
Maryam Rezaei
NKNadia Kazemipour
Nadia Kazemipour
JVJalil Vandyousefi
Jalil Vandyousefi
FRFarokh Rokhbakhshzamin
Farokh Rokhbakhshzamin
GIGholamreza Irajian
Gholamreza Irajian
Background and Aims: Listeria monocytogenes, a gram positive, facultative, intracellular bacterium is the causative agent of listeriosis that is transmitted to human through raw and ready-to-eat foods. The aim of the present study was to determine dominant serovars of L. monocytogenes isolated from spontaneous abortion using phenotypic and genotypic methods. Materials ...

2 September 2021 in Current Pharmaceutical Biotechnology
Verified
Journal Article
Open access
PDF file
ZAZahra Alikhani
Zahra Alikhani
NKNadia Kazemi-Pour
Nadia Kazemi-Pour
MAMehdi Shafiee Ardestani
Mehdi Shafiee Ardestani
MNMojtaba Noofeli
Mojtaba Noofeli
Background: Lately, the employment of nano-carriers has been known as an optimistic means of drug and vaccine delivery. Objective: Nano vaccines are a novel tier of vaccines that can develop humoral and cellular immune responses and can be introduced as a practical and secure nano vaccine candidate for the prevention of diseases. The purpose of this study was to accomplish and use biodegradable nano-carriers for the synthesis of pentavalent vaccine and immunogenicity evaluation in the animal models. The PLGA nanoparticle was prepared and modified with chitosan nanoparticles. Nano-carrier PLGA-chitosan was loaded by the DTP-HepB-Hib antigens and confirmed by DLS, SEM, TEM and FT-IR, then in vitro loading and release were evaluated. Toxicity was assessed by the MTT method in the Hec293 cells. Antigenicity evaluation and histopathological study were conducted by injection of new nano pentavalent vaccines in the BALB/c mice and the immune response was measured in the serum samples through an indirect ELISA method. Results: Conclusions drawn from the current study exhibited the plausible ability of nano-carrier to deliver the vaccine. A notable increase was shown in total IgG and IgM antibodies examined in mice vaccinated with new nano vaccines. The histopathological study in the treated mice showed no toxicity in the vital organs of mice. Conclusion: The engineered vaccine delivery system showed the ability to induce robust immune responses and also the suitability features of the PLGA-chitosan as a promising carrier to improve vaccine delivery.

24 February 2026 in Jundishapur Journal of Microbiology
Verified
Journal Article
Open access
NFNeda Fazeli
Neda Fazeli
BKBabak Kheirkhah
Babak Kheirkhah
NKNadia Kazemipour
Nadia Kazemipour
Background: Mycoplasma hominis and M. genitalium have been associated with reproductive health issues and may contribute to infertility, although causal links remain unclear. Data on their prevalence and antimicrobial susceptibility in southern Iran are limited. Objectives: To assess the molecular prevalence, species distribution, and antimicrobial susceptibility of M. hominis and M. genitalium among fertile and infertile individuals in Bandar Abbas, Hormozgan province, southern Iran. Methods: In this cross-sectional study conducted in 2024, 200 participants (100 infertile and 100 fertile) provided clinical samples — 100 semen samples from men and 100 endocervical swabs from women. Fertility status was clinically confirmed for all participants. Samples were enriched in pleuropneumonia-like organism (PPLO) broth, analyzed by polymerase chain reaction (PCR) targeting the 16S rRNA gene for genus-level detection, followed by multiplex PCR for species identification. Minimum inhibitory concentrations (MIC) for azithromycin, erythromycin, and moxifloxacin were determined using the 96-well microdilution method. Data were analyzed using SPSS v29, with P < 0.05 considered statistically significant. Results: Among 200 samples, 41 (20.5%) were positive for Mycoplasma: 22 men (20 infertile, 2 fertile) and 19 women (16 infertile, 3 fertile). Multiplex PCR identified 26 isolates as M. genitalium (12 infertile men, 2 fertile men; 10 infertile women, 2 fertile women) and 15 isolates as M. hominis (8 infertile men, 0 fertile men; 6 infertile women, 1 fertile woman). Although minor differences were observed between sexes (22% of men vs 19% of women), these were not statistically significant (P > 0.05). Macrolide resistance was detected in 6 M. genitalium and 4 M. hominis isolates, while moxifloxacin resistance was rare, found in only one M. genitalium isolate. Conclusions: Mycoplasma hominis and M. genitalium are present in both fertile and infertile individuals in southern Iran, with higher macrolide resistance in M. genitalium. While these organisms may influence reproductive health, causal associations cannot be confirmed. Routine molecular detection and species-specific antimicrobial testing are recommended, and larger longitudinal studies are needed to clarify their potential role in infertility.